Governor Maura Healey will now appoint all members of a reformed Cannabis Control Commission following her signing of a bill that introduces significant changes to Massachusetts’ marijuana industry. These changes aim to enhance the regulatory framework governing cannabis and to adapt to market demands.
Revised Commission Structure
Under the new law, the commission will be reduced from five to three members. Previously, appointments were shared among the governor, treasurer, and attorney general, reflecting a more streamlined approach to oversight.
Impacts on Consumers and Sellers
The reforms will facilitate greater accessibility for both consumers and retailers in the recreational marijuana market. The legal limit for personal purchase and public possession will increase from one ounce to two ounces, which equates to over $200 worth of cannabis.
Additionally, recreational dispensaries will now be permitted to hold up to six licenses. Lawmakers believe this will enable businesses to distribute overhead costs more effectively, combating the challenges posed by record-low prices and recent dispensary closures. The previous limitation of three licenses was designed to protect small businesses from larger market operators.
Support for Smaller Businesses
The legislation also eases requirements for medical marijuana businesses, allowing them not to grow their own cannabis. This change is expected to create more opportunities for smaller enterprises, thus diversifying the market landscape.
“It’s important that we are doing everything we can to make sure this industry is set up for success and that we remain competitive in this fast-growing market,” Healey stated. “I’m grateful to the Legislature for their leadership on this critical reform bill.”
Additional Compliance Measures
Further modifications include the establishment of a portal for anonymously reporting suspected illegal activity by licensed operators. A “delinquent” list will also be created for cannabis companies that fail to meet financial obligations, which will restrict their ability to operate until debts are resolved. Moreover, the commission will intensify its scrutiny of unregulated sales of hemp-infused products and cannabinoids, such as THC and CBD.